TLSI – trisalus life sciences, inc. (US:NASDAQ)

News

TriSalus Life Sciences, Inc. (NASDAQ: TLSI) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $10.00 price target on the stock.
TriSalus Life Sciences, Inc. (TLSI) Q2 2024 Earnings Call Transcript [Seeking Alpha]
TriSalus Reports Q2 2024 Financial Results and Business Update
TriSalus Life Sciences to Host Second Quarter 2024 Financial Results Conference Call
TriSalus Life Sciences Announces Completion of Exchange Offer and Consent Solicitation [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com